Post-mastectomy pain syndrome (PMPS) is chronic pain after breast cancer surgery and is reported to influence quality of life (QOL). Although the results of a survey in Japan showed high incidence, at 21–65 %, many of the patients had never been treated for PMPS. One reason for this low treatment rate may be poor understanding of PMPS by medical personnel. In this study, we conducted the survey by using questionnaire to assess current treatment and the recognitions of the medical personnel.
We mailed a questionnaire to 647 specialist members of the Breast Cancer Society.
Of those, 34.7 % responsed. While PMPS was recognized by as much as 70.5 % of responding physicians, it was treated by as little as 47.7 % of the responders. In addition, while non-steroidal anti-inflammatory drugs (NSAIDs), which were ineffective in relieving PMPS, were used by 78.4 % of the responders, effective drugs were rarely used; therefore, treatment was considered ineffective by 69.5 %. This indicates that appropriate therapies are not widely used, and none of the current therapies are very effective.
The results showed high recognition of PMPS pathology among physicians, but the treatment rate was as low as 47.7 %. NSAIDs were the main treatment, and the treatment effects were not satisfactory. It was revealed that currently appropriate treatment modalities have not been widely used. Education of physicians, distribution of treatment information and further studies are considered necessary for the spread of appropriate treatment modality.
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Tax calculation will be finalised during checkout.
Maunsell E, Brisson J, Deschenes L. Arm problems and psychological distress after surgery for breast cancer. Can J Surg. 1993;36(4):315–20.
Kwekkeboom K. Postmastectomy pain syndromes. Cancer Nurs. 1996;19(1):37–43.
Wallace MS, Wallace AM, Lee J, Dobke MK. Pain after breast surgery: a survey of 282 women. Pain. 1996;66(2–3):195–205.
Smith WC, Bourne D, Squair J, Phillips DO, Chambers WA. A retrospective cohort study of post mastectomy pain syndrome. Pain. 1999;83(1):91–5.
Stevens PE, Dibble SL, Miaskowski C. Prevalence, characteristics, and impact of postmastectomy pain syndrome: an investigation of women’s experiences. Pain. 1995;61(1):61–8.
Harold Merskey NB. Classification of chronic pain. In: Harold Merskey NB, editor. Postmastectomy pain syndrome. 2 ed. Seattle: IASP Press; 1994. p. 142.
Vecht CJ, Van de Brand HJ, Wajer OJ. Post-axillary dissection pain in breast cancer due to a lesion of the intercostobrachial nerve. Pain. 1989;38(2):171–6.
Carpenter JS, Andrykowski MA, Sloan P, Cunningham L, Cordova MJ, Studts JL, et al. Postmastectomy/postlumpectomy pain in breast cancer survivors. J Clin Epidemiol. 1998;51(12):1285–92.
Montazeri A. Health-related quality of life in breast cancer patients: a bibliographic review of the literature from 1974 to 2007. J Exp Clin Cancer Res. 2008;27:32.
Poleshuck EL, Katz J, Andrus CH, Hogan LA, Jung BF, Kulick DI, et al. Risk factors for chronic pain following breast cancer surgery: a prospective study. J Pain. 2006;7(9):626–34.
Peuckmann V, Ekholm O, Rasmussen NK, Groenvold M, Christiansen P, Moller S, et al. Chronic pain and other sequelae in long-term breast cancer survivors: nationwide survey in Denmark. Eur J Pain. 2009;13(5):478–85.
McMahon SB, Koltzenburg M. The assessment of cancer pain. In: McMahon SB, Koltzenburg M, editors. Textbook of pain. 5th ed. London: Churchill Livingstone; 2006. p. p1118.
Macdonald L, Bruce J, Scott NW, Smith WC, Chambers WA. Long-term follow-up of breast cancer survivors with post-mastectomy pain syndrome. Br J Cancer. 2005;92(2):225–30.
Saxena AK, Kumar S. Management strategies for pain in breast carcinoma patients: current opinions and future perspectives. Pain Pract. 2007;7(2):163–77.
Gartner R, Jensen MB, Nielsen J, Ewertz M, Kroman N, Kehlet H. Prevalence of and factors associated with persistent pain following breast cancer surgery. JAMA. 2009;302(18):1985–92.
Polinsky ML. Functional status of long-term breast cancer survivors: demonstrating chronicity. Health Soc Work. 1994;19(3):165–73.
Kojima KY. Postmastectomy pain syndrome. Nihon Rinsho. 2007;65(Suppl 6):582–6.
Carpenter JS, Sloan P, Andrykowski MA, McGrath P, Sloan D, Rexford T, et al. Risk factors for pain after mastectomy/lumpectomy. Cancer Pract. 1999;7(2):66–70.
The Japanese Breast Cancer Society. Investigative Report on Registration of Breast Cancer Patients in Japan. Tokyo: The Japanese Breast Cancer Society, 2002. p. 11.
Andersen KG, Kehlet H. Persistent pain after breast cancer treatment: a critical review of risk factors and strategies for prevention. J Pain. 2011;12(7):725–46.
Kehlet H, Jensen TS, Woolf CJ. Persistent postsurgical pain: risk factors and prevention. Lancet. 2006;367(9522):1618–25.
Reuben SS. Chronic pain after surgery: what can we do to prevent it. Curr Pain Headache Rep. 2007;11(1):5–13.
Ravenscroft AJ. Chronic pain after spinal cord injury: a survey of practice in spinal injury units in the USA. Spinal Cord. 2000;38(11):658–60.
van Gijn J, Bierman WF, Zuketto C, Rooijmans HG. Chronic, unexplained pain: from complaint to action. Ned Tijdschr Geneeskd. 2000;144(14):641–4.
Green CR, Wheeler JR, Marchant B, LaPorte F, Guerrero E. Analysis of the physician variable in pain management. Pain Med. 2001;2(4):317–27.
Ure BM, Troidl H, Neugebauer E, Edelmann M. Acute pain in surgery: the significance of a neglected problem. Langenbecks Arch Chir. 1992;377(6):352–9.
Dworkin RH, O’Connor AB, Backonja M, Farrar JT, Finnerup NB, Jensen TS, et al. Pharmacologic management of neuropathic pain: evidence-based recommendations. Pain. 2007;132(3):237–51.
Haanpaa ML, Gourlay GK, Kent JL, Miaskowski C, Raja SN, Schmader KE, et al. Treatment considerations for patients with neuropathic pain and other medical comorbidities. Mayo Clin Proc. 2010;85(3 Suppl):S15–25.
Kalso E, Tasmuth T, Neuvonen PJ. Amitriptyline effectively relieves neuropathic pain following treatment of breast cancer. Pain. 1996;64(2):293–302.
Tasmuth T, Hartel B, Kalso E. Venlafaxine in neuropathic pain following treatment of breast cancer. Eur J Pain. 2002;6(1):17–24.
The Japanese Breast Cancer Society. CQ34: Is medication against Postmastectomy pain syndrome (PMPS) effective? In: The Japanese Breast Cancer Society, editor. Clinical Practice Guideline of Breast Cancer, treatment. Tokyo: The Japanese Breast Cancer Society; 2011. p. 254–55.
Macrae WA. Chronic pain after surgery. Br J Anaesth. 2001;87(1):88–98.
This survey was conducted with the cooperation of the Japanese Breast Cancer Society as a part of research for “Standardization of Treatment of Chronic Pain after Breast Cancer Surgery” as a part of a 2007 Grant-in-Aid for Cancer Research from the Ministry of Health, Labour and Welfare “Research on Technical Improvement of Supportive Treatment and Palliative Treatment for Cancer Patients.” All authors declared no conflicts of interest. We would like to express our appreciation to the many specialists of the Japanese Breast Cancer Society for their cooperation.
About this article
Cite this article
Kojima, K.Y., Kitahara, M., Matoba, M. et al. Survey on recognition of post-mastectomy pain syndrome by breast specialist physician and present status of treatment in Japan. Breast Cancer 21, 191–197 (2014). https://doi.org/10.1007/s12282-012-0376-8
- Breast Cancer
- Post-mastectomy pain syndrome
- Recognition by physicians
- Quality of life